MedTrace Logo

SDM Laser for Non Central Diabetic CSME

NCT03226951 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2018-10-29

No results posted yet for this study

Summary

Is to determine if SDM laser can reduce macular thickness in non central CSME and stop the progression of non central CSME to central CSME in compare to glycemic control

Conditions

  • Non Central Diabetic Macular Edema

Interventions

DEVICE

Subthreshold 532nm laser

Subthershold 532nm laser

Sponsors & Collaborators

  • Marashi Eye Clinic

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-01-31
Completion
2018-02-01

Countries

  • Syria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03226951 on ClinicalTrials.gov